Vandyke, Thomas H <br/><br/>
Cost avoidance from dose rounding biologic and cytotoxic antineoplastics.  [electronic resource] 

 -  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners  Jul 2017 
 - 379-383 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1477-092X 
<br/><br/><label>Standard No.: </label>10.1177/1078155216639756  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Biological Products--administration & dosage<br/>Body Surface Area<br/>Body Weight<br/>Cost Savings--statistics & numerical data<br/>Drug Costs--statistics & numerical data<br/>Humans<br/>Pharmacy Service, Hospital--methods